Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,789,706
+$2,155,420 QoQ
Shares Held
74,669
-2.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#636
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Busey Bank holds $188,654,807 across 11 Drug Manufacturers - General names. ABBV ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,214 | $70,404,039 | |
| 2 | LLY |
ELI LILLY & Co
|
33,809 | $40,551,532 | |
| 3 | AMGN |
Amgen Inc
|
82,379 | $29,831,083 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
74,669 | $18,789,706 | |
| 5 | PFE |
Pfizer Inc
|
658,872 | $15,865,637 | |
| 6 | MRK |
Merck & Co., Inc.
|
76,140 | $9,783,989 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
37,053 | $2,134,993 | |
| 8 | NVS |
Novartis AG
|
2,452 | $384,276 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,789,706 | 74,669 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $16,634,286 | 76,483 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $18,034,486 | 78,929 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $18,594,513 | 80,308 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $14,903,800 | 80,292 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $16,894,854 | 80,636 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,534,438 | 81,792 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $16,292,099 | 82,500 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $14,165,836 | 82,590 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $15,299,313 | 84,016 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $13,346,480 | 86,123 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $10,268,594 | 68,889 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $9,968,942 | 73,992 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $11,915,616 | 74,767 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $12,386,112 | 76,642 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $10,470,929 | 78,019 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $12,068,394 | 78,796 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $13,306,798 | 82,085 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $11,433,040 | 84,439 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $9,358,801 | 86,760 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,507,081 | 48,891 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $5,130,709 | 47,410 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $5,016,119 | 46,814 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $4,169,108 | 47,598 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $4,739,540 | 48,274 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $4,318,905 | 56,686 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||